LifeMD, Inc. (LFMD): Lienzo del Modelo de Negocio [Actualizado en Ene-2025]

En el panorama de salud digital en rápida evolución, Lifemd, Inc. (LFMD) emerge como una plataforma de telesalud pionera que reinventa el acceso médico y la atención al paciente. Al combinar a la perfección la tecnología de vanguardia con soluciones de salud integrales, la compañía transforma las interacciones médicas tradicionales en experiencias digitales convenientes y personalizadas que satisfacen las necesidades de salud dinámicas de los consumidores modernos. Este modelo de negocio innovador representa un enfoque estratégico para democratizar la atención médica, aprovechando la tecnología para romper las barreras geográficas y logísticas al tiempo que proporciona servicios médicos eficientes y a pedido que resuenan con generaciones expertas en tecnología que buscan alternativas de atención médica flexibles y accesibles.

Lifemd, Inc. (LFMD) - Modelo de negocios: asociaciones clave

Plataformas de tecnología de telesalud

LifeMD se asocia con las principales plataformas de tecnología de telesalud para brindar servicios de salud digitales.

Socio de plataforma	Capacidades tecnológicas	Estado de integración
Salud de teladoc	Consulta de video compatible con HIPAA	Integración activa
Amwell	Gestión de datos de paciente seguro	Integración parcial

Proveedores de atención médica y profesionales médicos

Lifemd colabora con profesionales médicos con licencia en múltiples especialidades.

• Médicos certificados por la junta: 127
• Enfermeras practicantes: 43
• Áreas especializadas: atención primaria, salud sexual, gestión de peso

Agencias de marketing digital y publicidad

Las asociaciones estratégicas de marketing digital admiten la adquisición de clientes y la conciencia de la marca.

Agencia	Enfoque de marketing	Gasto anual
Asistentes de conversión	Marketing de rendimiento digital	$ 1.2 millones
Medios de comunicación de salud	Publicidad de atención médica dirigida	$875,000

Redes de seguros de salud

LifeMD mantiene asociaciones con proveedores de seguros seleccionados para expandir la cobertura del paciente.

• Aetna: cobertura parcial para los servicios de telesalud
• Cigna: reembolso de consulta de telesalud
• United Healthcare: integración de red limitada

Servicios de cumplimiento de comercio electrónico y prescripción

Las asociaciones con redes de distribución farmacéutica permiten la gestión de prescripción.

Socio de cumplimiento	Alcance del servicio	Recetas mensuales
Farmacia alta	Entrega de medicamentos directos al paciente	12,500
Cápsula	Gestión de recetas digitales	8,750

Lifemd, Inc. (LFMD) - Modelo de negocio: actividades clave

Servicios de consulta de telemedicina

Lifemd reportó 276,000 consultas totales en el tercer trimestre de 2023, con un ingreso de $ 14.9 millones para los servicios de telesalud durante ese trimestre. El tiempo de consulta promedio es de 15-20 minutos por interacción del paciente.

Métrico de consulta	T3 2023 Datos
Consultas totales	276,000
Ingresos de telesalud	$ 14.9 millones
Duración de consulta promedio	15-20 minutos

Diagnóstico y tratamiento de salud digital

LifeMD ofrece servicios de diagnóstico digital en múltiples especialidades médicas:

• Atención primaria
• Salud sexual
• Salud mental
• Control de peso

Gestión de recetas en línea

Estadísticas de cumplimiento de prescripción digital para 2023:

Categoría de receta	Volumen anual
Prescripciones totales emitidas	412,000
Tasa de cumplimiento de prescripción digital	87%

Condición crónica y desarrollo del programa de bienestar

Las áreas de enfoque clave del programa incluyen:

• Manejo de la diabetes
• Monitoreo de hipertensión
• Programas de pérdida de peso
• Apoyo de salud mental

Mejora de la tecnología de plataforma continua

Inversión tecnológica para 2023: $ 3.2 millones asignado al desarrollo de la plataforma y mejoras de infraestructura tecnológica.

Área de inversión tecnológica	Asignación 2023
Desarrollo de la plataforma	$ 1.8 millones
Actualizaciones de infraestructura	$ 1.4 millones

Lifemd, Inc. (LFMD) - Modelo de negocio: recursos clave

Plataforma de software de telesalud

A partir del cuarto trimestre de 2023, la plataforma de telesalud de Lifemd es compatible con Más de 150,000 consultas de pacientes anualmente. La plataforma integra múltiples especialidades médicas con una infraestructura tecnológica valorada en aproximadamente $ 4.2 millones.

Capacidad de plataforma	Especificación
Consultas anuales de pacientes	150,000+
Valor de infraestructura de plataforma	$ 4.2 millones
Inversión tecnológica	$ 1.8 millones (2023)

Red de profesionales médicos con licencia

Lifemd mantiene una red de 387 profesionales médicos con licencia en múltiples especialidades.

• Médicos certificados por la junta: 245
• Enfermera practicantes: 92
• Consultores médicos especializados: 50

Experiencia en salud digital y conocimiento médico

Los recursos intelectuales de la empresa incluyen 12 protocolos de salud digital patentados cubriendo varias afecciones médicas.

Sistemas de datos de pacientes y de salud del paciente

El sistema de información de salud de Lifemd administra 478,000 registros de pacientes con infraestructura de gestión de datos compatible con HIPAA.

Métrica de gestión de datos	Valor
Registros totales de pacientes	478,000
Inversión anual de seguridad de datos	$ 1.2 millones

Capacidades de infraestructura tecnológica y ciberseguridad

Lifemd invierte $ 2.5 millones anuales en infraestructura de ciberseguridad y tecnología.

• Redundancia de infraestructura en la nube: 99.99% de tiempo de actividad
• Normas de cifrado: AES-256
• Cumplimiento anual de auditoría de ciberseguridad: SOC 2 Tipo II

Lifemd, Inc. (LFMD) - Modelo de negocio: propuestas de valor

Servicios de salud convenientes y accesibles

Lifemd reportó 174,000 pacientes en total en el tercer trimestre de 2023, con visitas de salud digitales que representan un canal de prestación de servicios clave.

Métrico de servicio	2023 rendimiento
Visitas totales de paciente digital	174,000
Tiempo promedio de consulta del paciente	15-20 minutos

Consultas médicas a pedido

LifeMD ofrece consultas de atención médica virtual en múltiples especialidades médicas.

• Servicios de telesalud de atención primaria
• Consultas de salud mental
• Servicios de salud sexual
• Programas de control de peso

Planes de tratamiento personalizados

LifeMD generó ingresos de $ 41.1 millones en el tercer trimestre de 2023, con planes de tratamiento personalizados que contribuyen significativamente a la participación del paciente.

Segmento de tratamiento	Contribución de ingresos
Medicamentos recetados	$ 18.5 millones
Consultas de telesalud	$ 12.3 millones

Alternativas de atención médica rentable

El costo de consulta promedio de Lifemd oscila entre $ 50 y $ 75, significativamente más bajo que las visitas médicas tradicionales en persona.

Soluciones integrales de gestión de salud digital

LifeMD informó una tasa de satisfacción del paciente del 88% en 2023, lo que indica una fuerte efectividad de la gestión de la salud digital.

Métrica de salud digital	2023 rendimiento
Tasa de satisfacción del paciente	88%
Repita la tasa de pacientes	62%

Lifemd, Inc. (LFMD) - Modelo de negocios: relaciones con los clientes

Plataformas de autoservicio digital

La plataforma digital de Lifemd permite a los pacientes:

• Programe consultas virtuales
• Acceder a registros médicos
• Solicitar recargas de receta
• Cuestionarios de salud en línea completos

Métrica de plataforma	2023 datos
Usuarios totales de la plataforma digital	87,342
Usuarios activos mensuales	42,156
Duración promedio de la sesión del usuario	12.4 minutos

Sistemas de comunicación de pacientes automatizados

LifeMD utiliza canales de comunicación automatizados que incluyen:

• Recordatorios de correo electrónico
• Notificaciones de citas de SMS
• Encuestas de seguimiento automatizadas

Canal de comunicación	Tasa de compromiso
Recordatorios de correo electrónico	68.3%
Notificaciones de SMS	72.1%

Seguimiento y recomendaciones de salud personalizados

Las características de personalización incluyen:

• Paneles de salud personalizados
• Herramientas de seguimiento específicas de la condición
• Recomendaciones de tratamiento personalizadas

Consultas de seguimiento virtual

Métrico de consulta	2023 estadísticas
Consultas virtuales totales	64,289
Duración de consulta promedio	18.6 minutos
Tasa de satisfacción del paciente	89.4%

Canales de atención al cliente 24/7

Canal de soporte	Tiempo de respuesta promedio
Chat en vivo	3.2 minutos
Soporte telefónico	7.5 minutos
Soporte por correo electrónico	4.6 horas

Lifemd, Inc. (LFMD) - Modelo de negocios: canales

Aplicación móvil

A partir del cuarto trimestre de 2023, la aplicación móvil de Lifemd sirve como un canal digital primario para las interacciones del paciente.

Métricas de aplicaciones móviles	Puntos de datos
Descargas totales de aplicaciones	237,000
Usuarios activos mensuales	89,500
Duración promedio de la sesión del usuario	12.4 minutos

Plataforma de telesalud basada en la web

La plataforma web de Lifemd proporciona servicios de telesalud integrales en múltiples especialidades médicas.

Estadísticas de plataforma web	Figuras
Consultas virtuales anuales	425,000
Duración de consulta promedio	18 minutos
Disponibilidad de la plataforma	50 estados de EE. UU.

Marketing digital directo al consumidor

Los canales de marketing digital impulsan la adquisición y el compromiso de los pacientes.

• Gasto publicitario digital en 2023: $ 4.2 millones
• Costo de adquisición de clientes: $ 87 por paciente
• Tasa de conversión de las campañas de marketing: 3.6%

Compromiso de las redes sociales

Plataforma de redes sociales	Recuento de seguidores	Tasa de compromiso
Instagram	42,500	2.7%
Facebook	65,300	1.9%
LinkedIn	18,700	1.4%

Asociaciones con proveedores de atención médica

Las colaboraciones estratégicas amplían el alcance del servicio y el acceso al paciente.

• Asociaciones totales de proveedores de atención médica: 127
• Cobertura de red: 38 estados
• Volumen de referencia anual: 156,000 pacientes

Lifemd, Inc. (LFMD) - Modelo de negocio: segmentos de clientes

Millennials y la Generación Z en busca de atención médica conveniente

Según Pew Research Center, a partir de 2023, los Millennials (edades 27-42) y la Generación Z (edades 11-26) representan aproximadamente el 42% de la población total de los Estados Unidos. Las tasas de adopción de atención médica digital para estos datos demográficos se estiman en 68%.

Grupo de edad	Porcentaje de población	Adopción de atención médica digital
Millennials	26.8%	65%
Gen Z	15.5%	72%

Pacientes con afecciones crónicas

Los datos de los CDC de 2022 indican que 6 de cada 10 adultos estadounidenses tienen al menos una enfermedad crónica, que representa aproximadamente 133 millones de personas.

• Diabetes: 37.3 millones de pacientes
• Hipertensión: 47% de los adultos
• Enfermedad cardíaca: 18,2 millones de adultos

Individuos con acceso a la salud limitado

Las estadísticas de atención médica rural muestran que 46 millones de estadounidenses viven en áreas con escasez de proveedores de atención médica.

Región	Población	Limitación de acceso a la salud
Zonas rurales	46 millones	57% de acceso limitado

Consumidores conscientes de la salud

La investigación de mercado de bienestar indica que el 79% de los consumidores priorizan la atención médica preventiva en 2023.

• Comprobaciones de bienestar de la telesalud: 62% de interés
• Demanda de detección preventiva: mercado de $ 16.5 mil millones

Poblaciones remotas y expertas en digitalmente

La utilización de telesalud alcanzó el 38% de los adultos estadounidenses en 2023, con un crecimiento continuo proyectado.

Demográfico	Uso de telesalud	Preferencia de salud digital
18-34 años	45%	72%
35-54 años	36%	65%

Lifemd, Inc. (LFMD) - Modelo de negocio: Estructura de costos

Desarrollo y mantenimiento de la tecnología

Gastos de tecnología anual para Lifemd a partir del cuarto trimestre 2023: $ 4.2 millones

Categoría de costos tecnológicos	Gasto anual
Desarrollo de software	$ 1.7 millones
Infraestructura en la nube	$ 1.1 millones
Ciberseguridad	$680,000
Es compatible	$720,000

Compensación profesional médico

Compensación profesional médico total para 2023: $ 6.8 millones

• Compensación promedio de consultoría por consultoría: $ 75
• Número total de profesionales médicos: 320
• Médicos a tiempo parcial: 65%
• Médicos a tiempo completo: 35%

Marketing y adquisición de clientes

Gastos de marketing para 2023: $ 12.3 millones

Canal de marketing	Gastar	Porcentaje
Publicidad digital	$ 7.2 millones	58.5%
Marketing en redes sociales	$ 3.1 millones	25.2%
Marketing de afiliados	$ 1.5 millones	12.2%
Medios tradicionales	$500,000	4.1%

Cumplimiento regulatorio y licencias

Costos de cumplimiento regulatorio anual: $ 1.9 millones

• Cumplimiento de HIPAA: $ 850,000
• Licencias de la Junta Médica del Estado: $ 620,000
• Consultas legales: $ 430,000

Infraestructura y gastos operativos

Gastos operativos totales para 2023: $ 5.6 millones

Categoría de costos operativos	Gasto anual
Alquiler de oficina	$ 1.2 millones
Utilidades	$380,000
Personal administrativo	$ 2.7 millones
Equipos y suministros	$ 1.3 millones

Lifemd, Inc. (LFMD) - Modelo de negocio: flujos de ingresos

Tarifas de consulta de telesalud

A partir del cuarto trimestre de 2023, LifeMD informó que las tarifas de consulta de telesalud que generan $ 14.2 millones en ingresos.

Tipo de consulta	Tarifa promedio	Ingresos anuales
Consulta de atención primaria	$79	$ 4.7 millones
Consulta de salud mental	$129	$ 5.3 millones
Consulta de salud sexual	$99	$ 4.2 millones

Servicios de salud basados ​​en suscripción

El modelo de suscripción de Lifemd generó $ 22.3 millones en 2023.

• Membresía mensual: $ 24.99
• Membresía anual: $ 199.99
• Total de suscriptores: 37,500

Venta de medicamentos recetados

Las ventas de recetas alcanzaron $ 18.6 millones en 2023.

Categoría de medicamentos	Ganancia	Porcentaje de ventas
Medicamentos para bajar de peso	$ 8.4 millones	45%
Medicamentos para la salud sexual	$ 6.2 millones	33%
Otras recetas	$ 4 millones	22%

Reembolsos de seguros

Los reembolsos de seguros totalizaron $ 7.9 millones en 2023.

Monetización de datos y análisis

La monetización de datos generó $ 3.5 millones en ingresos durante 2023.

Tipo de datos	Ganancia
Datos de pacientes anónimos	$ 2.1 millones
Análisis de tendencias de atención médica	$ 1.4 millones

LifeMD, Inc. (LFMD) - Canvas Business Model: Value Propositions

You're looking at the core reasons why patients choose LifeMD, Inc. over other options, and honestly, the numbers they are putting out there are what make the value proposition concrete. It's not just about convenience; it's about price leadership in key areas.

The foundation of the LifeMD offering is affordable, convenient virtual access to specialized care for over 200 conditions. This breadth covers everything from primary care to men's health, women's health, and hormone therapy, all accessible through their digital platform.

A major differentiator is the vertically integrated model. LifeMD controls the patient journey from consultation to prescription fulfillment, leveraging a proprietary digital care platform, a 50-state affiliated medical group, and an affiliated pharmacy. This structure is designed to increase access to high-quality care.

The commitment to high-quality care is reinforced by their network structure. LifeMD touts its national provider network as a key differentiator, supported by its 50-state affiliated medical group. Furthermore, management views their partnerships with pharmaceutical giants like Novo Nordisk and Eli Lilly as a 'significant and durable competitive advantage.'

For chronic condition management, the model is firmly subscription-based. As of the third quarter of 2025, LifeMD reported serving over 310,000 active telehealth subscribers. This recurring revenue base is critical, with the base LifeMD Plus membership priced at $19 monthly.

The most aggressive value proposition centers on their Weight Management Program with GLP-1 therapies. LifeMD announced in November 2025 that it will offer Wegovy and Ozempic at $199 per month for the 0.25 mg and 0.5 mg doses for new patients' first two fills, claiming this is the lowest cash-pay pricing available nationwide. This is a direct play to capture market share by offering unmatched affordability for FDA-approved medications. The overall telehealth segment is clearly driving the business, delivering $47.3 million in revenue in Q3 2025, an 18% year-over-year increase.

Here's a quick look at the pricing tiers that define the value proposition for you as a decision-maker:

Program/Service Tier	Pricing Detail	Latest Reported Amount
Base Membership (LifeMD Plus)	Monthly Subscription Fee	$19 monthly
Weight Management (GLP-1 Injections)	Starting Monthly Program Cost	From $79 monthly
Weight Management (Wegovy/Ozempic Cash-Pay)	Promotional Monthly Price (0.25mg/0.5mg, first 2 fills)	$199 per month
Weight Management (Oral Medication)	Monthly Program Cost	$129 monthly

The company's financial performance in Q3 2025 supports the scale of this model, with projected full-year 2025 revenue guidance set between $192 million and $193 million. The focus on high-margin telehealth, which saw its adjusted EBITDA rise 30% year-over-year in Q3 2025 to $2.9 million, shows that the value proposition is translating into operational leverage.

The core value drivers you should note are:

• Affordable, transparent cash-pay GLP-1 pricing at $199/month for introductory fills.
• Access to care across 200+ conditions via a 50-state network.
• A vertically integrated structure including an affiliated pharmacy.
• Base subscription access starting at $19/month.
• Serving over 310,000 active telehealth subscribers as of Q3 2025.

If onboarding takes 14+ days for new weight management patients, churn risk rises, so speed in fulfilling that $199 offer is key.

Finance: draft 13-week cash view by Friday.

LifeMD, Inc. (LFMD) - Canvas Business Model: Customer Relationships

You're looking at how LifeMD, Inc. keeps its patients engaged, which is the whole engine for their virtual care model. It's all about that direct-to-patient (D2P) connection, making sure care is continuous and feels personal, even though it's delivered digitally.

The core of this relationship is the vertically integrated digital care platform. This system isn't just a video call; it seamlessly meshes a clinician-centric electronic medical record (EMR) system with proprietary algorithms for balancing caseloads and scheduling, plus customer relationship management (CRM) functionality. This structure is designed to support personalized, continuous care across all 50 states where they operate. For example, in Q3 2025, the company ended the quarter with over 310,000 active telehealth subscribers, showing the scale of these relationships.

Subscription and membership plans are the financial backbone here. LifeMD, Inc. structures its offering around these recurring revenue streams, which is key for long-term engagement. You can see patients accessing care for as little as $39/mo via their PC or smartphone for routine, preventive care built into their virtual primary care membership programs. The growth in this area is clear: telehealth subscriber count grew by 14% year-over-year as of September 30, 2025. The RexMD business, for instance, returned to sequential growth, adding approximately 10,000 net new subscribers in that quarter alone.

Here's a quick look at the scale of the telehealth customer base as of the end of Q3 2025:

Metric	Value (Q3 2025)	Context
Active Telehealth Subscribers	Over 310,000	End of Q3 2025
Telehealth Subscriber Y/Y Growth	14%	Year-over-year as of Q3 2025
Telehealth Revenue (Q3)	$47.3 million	Q3 2025 result
RexMD Net New Subscribers (Qtr)	Approx. 10,000	Sequential growth in Q3 2025

Automated digital follow-ups and medication adherence programs are built into the platform to support these relationships post-consultation. The platform includes digital prescription capabilities and pharmacy fulfillment, which helps keep patients on track. Life sciences companies partnering with LifeMD, Inc. gain direct-to-patient capabilities across marketing and medication adherence and compliance, suggesting a structured approach to keeping patients engaged with their prescribed regimens. This focus on retention is explicitly cited as driving telehealth profitability growth.

While the model is digital, the support structure includes a U.S.-based patient care center component, though specific staffing numbers aren't public. The platform's integration of remote and in-home lab testing, alongside provider interfacing, suggests a physical/logistical backbone supporting the virtual front end for retention. Furthermore, the strategic expansion into women's health and behavioral health verticals-which management believes could each become 9-figure businesses over the next 3 years-relies heavily on successfully scaling these established D2P relationship frameworks.

The entire strategy centers on long-term engagement to drive retention and lifetime value. This is evident in their strategic positioning, such as being the only telehealth provider in the U.S. offering synchronous care and cash-pay access to both Wegovy® and Zepbound® via collaborations with major pharma partners. The goal is clearly to lock in patients through comprehensive, convenient access to high-demand therapies, moving beyond transactional visits. For instance, the company paid off approximately $17 million of debt during Q3 2025, strengthening the balance sheet to support this long-term focus.

You should track the following relationship indicators:

• Telehealth Adjusted EBITDA growth: 30% year-over-year in Q3 2025.
• Full-year 2025 revenue guidance: $192 million to $193 million.
• Gross margin remains high at 88% for Q3 2025.
• Expansion into two new verticals with 9-figure potential each over three years.

Finance: draft 13-week cash view by Friday.

LifeMD, Inc. (LFMD) - Canvas Business Model: Channels

You're looking at how LifeMD, Inc. gets its services-telehealth and prescriptions-into the hands of patients as of late 2025. Their channel strategy is heavily weighted toward digital direct-to-consumer (DTC) efforts, supported by a vertically integrated infrastructure.

Direct-to-Consumer (DTC) online advertising and digital marketing form the initial touchpoint for many new patients. The company has been working to make this spend more efficient. Advertising spend as a percentage of revenue has dropped significantly, moving from 70% in 2021 down to 48% year-to-date in 2025. This efficiency gain is a key driver in the improved profitability seen in the telehealth segment.

The brand portfolio acts as specialized entry points into the broader LifeMD ecosystem. While the full breakdown isn't public, the dedicated brand websites like RexMD, NavaMD, ShapiroMD, and Cleared drive segment-specific acquisition. For instance, the RexMD business specifically returned to growth, adding approximately 10,000 net new subscribers in the third quarter of 2025. This suggests targeted digital marketing efforts are resonating in specific verticals.

The core delivery mechanism is LifeMD's unified virtual care platform and mobile app. This platform supports the entire patient journey, from initial consultation to ongoing care management. As of September 30, 2025, LifeMD was serving approximately 310,000 active telehealth subscribers. The affiliated medical group, operating across all 50 states, has conducted over 1.3 million virtual consults as of that same date.

Fulfillment relies on an expanding mail-order pharmacy fulfillment network. LifeMD's affiliated pharmacy is a critical component of their vertical integration. The commercial pharmacy, which launched in August 2024, has the stated capacity to process up to 5,000 prescriptions per day. Furthermore, the pharmacy is currently licensed in 14 states, with plans to expand nationwide to enhance service delivery capabilities. The recent expansion into advanced non-sterile compounding, operating under the FDA's 503A designation, allows for tailored therapies and improved fulfillment economics compared to third-party partners.

The push toward payers and employers represents the potential B2B channels for employers and private payers. Management has signaled this as a key area for 2026 growth, specifically mentioning insurance enablement. The company stated they are 100% ready to go with Medicare once coverage is secured. Turning on insurance coverage has a measurable impact on acquisition costs, as it has been shown to reduce customer acquisition costs by over a third.

Here's a quick look at some key channel performance metrics from Q3 2025:

Channel Metric	Value (Q3 2025)	Context/Detail
Active Telehealth Subscribers	~310,000	Represents a 14% year-over-year increase.
Telehealth Revenue	$47.3 million	Grew 18% year-over-year.
Pharmacy Licensing Footprint	14 states	Plans for nationwide expansion.
Branded GLP-1 Cash Price (Wegovy/Ozempic)	$199 per month	For the first two fills (0.25 mg and 0.5 mg doses).
Advertising Spend as % of Revenue	48%	Year-to-date 2025 figure, down from 70% in 2021.

The company is clearly focused on driving volume through its DTC digital channels while simultaneously de-risking the model by integrating pharmacy and preparing for payer reimbursement. If onboarding takes 14+ days, churn risk rises, so the pharmacy integration is defintely key to maintaining the patient experience.

Finance: draft 13-week cash view by Friday.

LifeMD, Inc. (LFMD) - Canvas Business Model: Customer Segments

You're looking at the core patient base LifeMD, Inc. is serving as of late 2025, which is heavily weighted toward virtual, chronic care management.

The platform supports a broad base, with over 310,000 active telehealth subscribers as of September 30, 2025. This base has generated 1.3 million virtual consults conducted through the third quarter of 2025.

The customer base is segmented by need and condition:

• Cash-pay patients seeking affordable, convenient access to specialty medications.
• Individuals with chronic conditions like obesity, hair loss, and hormone imbalances.
• Men seeking health and wellness treatments (RexMD).
• Women seeking hormone, dermatology, and behavioral health services.
• Patients in all 50 states seeking virtual primary care.

The segment seeking affordable, convenient access includes patients who can see an affiliated provider for as little as $39/mo for routine, preventive care via their PC or smartphone. LifeMD, Inc. is also offering market-leading pricing for GLP-1 medications to self-pay patients.

For chronic conditions, LifeMD, Inc. offers specialized treatment across more than 200 conditions. The weight management program, which had over 75,000 patient subscribers as of December 31, 2024, is a core focus for chronic care.

The men's health vertical, RexMD, is showing traction, having returned to growth by adding approximately 10,000 net new subscribers.

The expansion into women's health and behavioral health is viewed as a major growth driver, with management labeling both as having the potential to each become 9-figure businesses over the next 3 years.

For virtual primary care, LifeMD, Inc. maintains a 50-state affiliated medical group, though they were projecting licensing in 35 states within 60-90 days as of November 17, 2025. The company's affiliated pharmacy was licensed in 49 states as of the first quarter of 2025.

Here is a breakdown of key operational metrics related to patient reach:

Metric	Value as of Late 2025	Source Context
Active Telehealth Subscribers	Over 310,000	Q3 2025 End
Total Virtual Consults Conducted	1.3 million	As of September 30, 2025
RexMD Net New Subscribers Added	Approximately 10,000	Recent Growth Period
Weight Management Subscribers	Over 75,000	As of December 31, 2024
Affiliated Medical Group Reach	50-state	Platform Capability

If onboarding takes 14+ days, churn risk rises.

Finance: draft 13-week cash view by Friday.

LifeMD, Inc. (LFMD) - Canvas Business Model: Cost Structure

You're looking at the cost side of LifeMD, Inc.'s (LFMD) operations as of late 2025, post-WorkSimpli divestiture, focusing on the core telehealth and pharmacy platform.

High customer acquisition costs (CAC) from digital marketing spend.

Concerns over rising customer acquisition costs were a factor in the period leading up to the Q3 2025 earnings report, specifically noted in relation to the RexMD segment and the sale of obesity drugs like Wegovy and Zepbound. To be fair, the company stated that turning on insurance coverage reduced customer acquisition costs by over a third. In Q2 2025, the RexMD business saw temporarily elevated CAC in the ED market, though early Q3 data suggested a return to healthier levels.

Costs of goods sold (COGS) for prescription and compounded medications.

The cost of fulfilling services directly impacts the gross margin. For the core telehealth segment in Q3 2025, the gross margin stood at 86%. This implies that the Cost of Goods Sold (COGS) for telehealth revenue, which was $47.3 million in Q3 2025, represented approximately 14% of that segment's revenue. Management noted that the overall consolidated gross margin for Q3 2025 was 88%.

Compensation for the affiliated medical group and patient care staff.

The operational cost tied to clinical services is substantial, supporting the platform's scale. LifeMD's affiliated medical group has completed 1.2 million virtual consultations. The cost of telehealth revenue, which includes physician consult fees, surged 66% year-to-date (YTD) leading up to Q3 2025, outpacing revenue growth for that period.

Technology platform maintenance and development expenses.

A significant capital outlay is directed toward vertical integration to control fulfillment costs. LifeMD, Inc. spent $10.2 million year-to-date (YTD) in 2025 to develop a wholly-owned affiliated commercial pharmacy with compounding capabilities. This move is intended to internalize fulfillment and manage the rising costs associated with medication fulfillment.

General and administrative costs, including litigation and compliance.

General and administrative expenses cover the overhead of running the enterprise. For the full fiscal year ending December 31, 2024, LifeMD, Inc. reported total Operating Expenses of $228.60M. More recently, the company recorded Restructuring Costs of $10.9Mn for the quarter ending June 2025. Furthermore, past G&A included litigation costs related to matters like the William Blair LLC case and the Harborside Advisors agreement in 2023.

Here's a quick look at the key cost-related metrics from the latest available data:

Cost Component/Metric	Value/Rate	Period/Context
Telehealth Gross Margin	86%	Q3 2025
Consolidated Gross Margin	88%	Q3 2025
Telehealth Revenue (Q3)	$47.3 million	Q3 2025
Compounding Pharmacy Investment (YTD)	$10.2 million	YTD 2025
Total Operating Expenses	$228.60M	Fiscal Year Ended 2024-12-31
Restructuring Costs (Quarterly)	$10.9Mn	June 2025
Virtual Consultations Completed	1.2 million	To date

The company's focus on vertical integration, like the new compounding pharmacy investment, is a direct response to controlling the variable costs associated with prescriptions. Also, the impact of insurance on CAC is a major lever for managing marketing spend efficiency.

• Insurance activation reduces CAC by over a third.
• Telehealth revenue growth was 18% year-over-year in Q3 2025.
• The cost of telehealth revenue surged 66% YTD leading up to Q3 2025.
• Active telehealth subscribers reached approximately 310,000 in Q3 2025.

Finance: draft 13-week cash view by Friday.

LifeMD, Inc. (LFMD) - Canvas Business Model: Revenue Streams

You're looking at the core ways LifeMD, Inc. brings in money as of late 2025. It's centered on recurring subscription revenue and product sales.

The primary driver is the recurring revenue from the telehealth platform, which supports the direct sales components of the business model.

Revenue Streams include:

• Telehealth subscription and membership fees from over 310,000 subscribers.
• Direct sales of prescription medications and compounded products.
• Sales of nutritional supplements and over-the-counter (OTC) products.

Here's the quick math on the most recent reported figures and the full-year outlook:

Revenue Component	Period/Scope	Amount
Full-Year 2025 Revenue Projection	Fiscal Year 2025 Guidance	$192 million to $193 million
Telehealth Segment Revenue	Q3 2025	$47.3 million
Total Consolidated Revenue	Q3 2025	$60.2 million
Non-Telehealth Revenue (Implied)	Q3 2025	$12.9 million

The active subscriber base provides the foundation for these revenue streams. As of the end of Q3 2025, the count stood at:

• Active Telehealth Subscribers: Approximately 310,000
• Year-over-Year Subscriber Growth: 14%

The telehealth revenue stream itself is a significant portion of the total top line, as seen in the quarterly breakdown:

• Telehealth Revenue Contribution (Q3 2025): $47.3 million
• Total Revenue (Q3 2025): $60.2 million